#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14504	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2093	687.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1671	1671	T	800	T,C	524,226	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14504	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2093	687.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	905	C	847	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14504	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2093	687.0	0	HET	.	.	.	C45T	.	45	45	C	266	266	C	856	C,T	618,174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	0	.	n	.	0	T695C	SNP	695	695	T	1056	1056	C	797	C	742	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	0	.	n	.	0	A1223G	SNP	1223	1223	A	1584	1584	G	841	G,A	784,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2332	2332	C	841	C,T	781,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2406	2406	A	907	A	852	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2958	2958	C	807	C,T	758,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26588	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3490	758.4	0	HET	.	.	.	T2772C	.	2772	2772	T	3133	3133	T	853	T,C	620,187	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1712	folP	855	855	100.0	folP.l6.c30.ctg.1	1310	128.7	1	SNP	p	R229S	1	.	.	685	687	AGC	916	918	AGC	174;174;175	A;G;C	169;169;169	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5272	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3505	149.9	0	.	p	.	0	G95A	NONSYN	283	285	GGC	659	661	GCC	199;199;198	G;C;C	180;182;183	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5272	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3505	149.9	1	SNP	p	S91F	1	.	.	271	273	TTC	647	649	TTC	190;190;195	T;T;C	179;178;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1438	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1185	119.4	1	SNP	p	G45D	1	.	.	133	135	GAC	474	476	GAC	174;174;175	G;A;C	162;162;165	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	758	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1040	72.5	0	.	n	.	0	A197.	DEL	197	197	A	640	640	A	173	A	164	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4864	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2943	164.8	1	SNP	p	D86N	0	.	.	256	258	GAC	537	539	GAC	180;180;180	G;A;C	164;164;167	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4864	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2943	164.8	1	SNP	p	R87I	0	.	.	259	261	CGT	540	542	CGT	178;176;177	C;G;T	166;164;166	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4864	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2943	164.8	1	SNP	p	S87R	1	.	.	259	261	CGT	540	542	CGT	178;176;177	C;G;T	166;164;166	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4864	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2943	164.8	1	SNP	p	R87W	0	.	.	259	261	CGT	540	542	CGT	178;176;177	C;G;T	166;164;166	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4864	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2943	164.8	1	SNP	p	S88P	0	.	.	262	264	TCC	543	545	TCC	175;174;175	T;C;C	164;159;165	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3670	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2475	147.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1477	1479	GGC	166;166;164	G;G;C	157;157;154	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1186	1188	GCA	187;190;193	G;C;A	176;174;184	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1189	1191	ATC	194;194;196	A,G;T;C	186,1;184;187	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1201	1203	GTG	192;188;186	G;T;G	181;177;175	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1201	1203	GTG	192;188;186	G;T;G	181;177;175	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1705	1707	ACC	211;208;212	A;C;C,T	193;196;198,1	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1759	1761	GCG	185;183;182	G;C;G	162;138;144	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1759	1761	GCG	185;183;182	G;C;G	162;138;144	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1882	1884	GGC	154;154;152	G;G;C	140;142;140	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1891	1893	GGC	155;151;152	G;G;C	141;138;139	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3646	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2283	158.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1909	1911	CCG	134;133;130	C,G;C;G	97,6;96;93	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5430	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3120	173.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1676	1678	CCG	201;198;197	C,T;C;G	178,1;185;180	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2060	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1722	118.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	331	333	GGC	151;151;155	G;G;C,T	136;134;134,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2060	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1722	118.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	513	513	C	144	C	133	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	A251V	NONSYN	751	753	GCG	82	84	GTA	35;35;35	G;T;A	33;33;33	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	142	144	ACT	37;36;31	A;C;T	32;30;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	148	150	GAT	18;15;12	G;A;T	16;13;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	151	153	AGT	12;12;12	A;G;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	160	162	CAC	12;12;12	C;A;C	10;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	250	252	GAA	6;7;7	G;A;A	6;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	262	264	GCA	8;8;8	G;C;A	7;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	265	267	GAC	8;8;8	G;A;C	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	271	273	ATC	8;8;8	A;T;C	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	277	279	TCG	8;8;8	T;C;G	8;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	283	285	GCC	7;7;7	G;C;C	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	286	288	AGC	7;7;7	A;G;C	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	289	291	GCC	6;6;6	G;C;C	6;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	220	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	434	14.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	295	297	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	T26A	NONSYN	76	78	ACC	414	416	GCC	233;235;236	G;C;C	217;219;221	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	K41D	NONSYN	121	123	AAA	459	461	GAC	233;230;231	G;A;C	219;215;216	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	A109V	NONSYN	325	327	GCC	663	665	GTC	228;230;232	G;T;C	207;201;204	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	695	696	CG	226;225	C;G	213;212	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	698	700	CAG	226;224;218	C,A;A;G	209,1;210;206	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	702	704	AAA	225;228;229	A;A;A	211;213;212	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	765	767	GAA	208;206;205	G;A;A	201;197;199	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	789	791	GCA	214;213;213	G;C,T,A;A	201;199,1,1;196	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	897	899	CAA	245;245;247	C;A,G;A	233;230,1;235	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	N189S	NONSYN	565	567	AAC	903	905	AGC	247;247;246	A;G;C	236;234;232	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	I209M	NONSYN	625	627	ATC	963	965	ATG	221;221;219	A;T;G	214;213;205	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	.	MULTIPLE	637	639	CAG	975	980	TATTTA	221;221;220;221;222;224	T;A;T;T;T;A	214;213;210;215;214;218	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	S216I	NONSYN	646	648	AGC	987	989	ATC	228;228;228	A;T;C	216;217;216	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	R256S	NONSYN	766	768	CGT	1107	1109	AGT	235;235;236	A;G;T	221;221;220	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1218	1220	AGT	248;248;240	A;G;T	228;229;218	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1224	1226	GAC	245;241;243	G;A;C	226;220;224	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	1	SNP	p	G120K	1	.	.	358	360	AAG	695	697	CGG	226;225;225	C;G;G	213;212;210	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	1	SNP	p	D121N	0	.	.	361	363	GAC	698	701	CGC	226;218;221	C,A;G;C	209,1;206;207	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2814	porB1b	1041	1041	96.94	porB1b.l15.c17.ctg.1	1527	183.6	1	SNP	p	A121D	1	.	.	361	363	GAC	698	701	CGC	226;218;221	C,A;G;C	209,1;206;207	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10384	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4770	217.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1152	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1192	96.2	1	SNP	p	V57M	1	.	.	169	171	ATG	641	643	ATG	242;243;246	A,G;T;G	227,1;230;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	11642	tetM	1920	1920	100.0	tetM.l6.c30.ctg.1	2595	447.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
